Main Products/ Services/ Pipelines & Platforms
Commercial status • PG2®Lyo. Injection is used for the treatment of cancer-related fatigue. • Oraphine® (nalbuphine HCl soft capsule) is used for the relief of moderate to severe acute pain. Clinical status (Phase II completed) • PHN031: osteoporosis prevention • PHN033: diabetic nephropathy • PG2®Lyo.combo therapy: cancer treatment
Business Interests
• Out-licensing of PG2® and Oraphine® • In-licensing of the products related to cancer supportive care, cancer therapy and neurology • Co-develop inline products in new indications
Contact Info
Alison Tsai
+886-2-2545-3697#2315
alison.tsai@phytohealth.com.tw<
Angel Lee
+886-2-2545-3697
angellee@maywufa.com.tw